Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

ICOSAPENT ETHYL

ICOSAPENT ETHYL

Standard Dose
500MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ICOSAPENT ETHYL is listed in Drugs@FDA under application 217919 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ICOSAPENT ETHYL Form and strength CAPSULE;ORAL - 500MG Sponsor HUMANWELL PURACAP Submission history Latest submission status date: 2023-12-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview ICOSAPENT ETHYL is listed in Drugs@FDA under application 217919 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ICOSAPENT ETHYL Form and strength CAPSULE;ORAL - 500MG Sponsor HUMANWELL PURACAP Submission history Latest submission status date: 2023-12-22 00:00:00. Submission type: ORIG.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.